Publications by authors named "Maria Bozi"

Claim this Profile
T
The novel p.A30G SNCA pathogenic variant in Greek patients with familial and sporadic Parkinson's disease.
Ioanna Alefanti, Christos Koros, Viktoria Tsami, Athina Maria Simitsi, Chrisoula Kartanou, Maria Bozi

Eur J Neurol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Jumping to conclusions bias, psychosis and impulsivity in early stages of Parkinson's disease.
Ioanna Pachi, Vassilis Papadopoulos, Lida Alkisti Xenaki, Christos Koros, Athina Maria Simitsi, Maria Bozi

J Neurol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson's Disease.
Ioanna Pachi, Vassilis Papadopoulos, Christos Koros, Athina Maria Simitsi, Anastasia Bougea, Maria Bozi

J Parkinsons Dis· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Landscape of Monogenic Parkinson's Disease in Populations of Non-European Ancestry: A Narrative Review.
Christos Koros, Anastasia Bougea, Athina Maria Simitsi, Nikolaos Papagiannakis, Efthalia Angelopoulou, Maria Bozi

Genes (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of APOE Genotype on Cognition in Idiopathic and Genetic Forms of Parkinson's Disease.
Christos Koros, Kathrin Brockmann, Athina-Maria Simitsi, Anastasia Bougea, Hui Liu, Maria Bozi

Mov Disord· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort.
Eva-Juliane Vollstedt, Susen Schaake, Katja Lohmann, Shalini Padmanabhan, Alexis Brice, Maria Bozi

Mov Disord· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical differences between early-onset and mid-and-late-onset Parkinson's disease: Data analysis of the Hellenic Biobank of Parkinson's disease.
Efthalia Angelopoulou, Maria Bozi, Athina-Maria Simitsi, Christos Koros, Roubina Antonelou

J Neurol Sci· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Uric Acid in LRRK2 Related Parkinson's Disease: Longitudinal Data from the PPMI Study.
Anastasia Bougea, Christos Koros, Nikolaos Papagiannakis, Athina-Maria Simitsi, Andreas Prentakis, Maria Bozi

J Parkinsons Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriers.
Ioanna Pachi, Christos Koros, Athina M Simitsi, Dimitra Papadimitriou, Anastasia Bougea, Maria Bozi

Parkinsonism Relat Disord· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Uric Acid Level as a Biomarker in Idiopathic and Genetic (p.A53T Alpha-Synuclein Carriers) Parkinson's Disease: Data from the PPMI Study.
Christos Koros, Athina-Maria Simitsi, Dimitra Papadimitriou, Anastasia Bougea, Andreas Prentakis, Maria Bozi

J Parkinsons Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel SNCA A30G Mutation Causes Familial Parkinson's Disease.
Hui Liu, Christos Koros, Timo Strohäker, Claudia Schulte, Maria Bozi

Mov Disord· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI study.
Christos Koros, Athina-Maria Simitsi, Nikolaos Papagiannakis, Anastasia Bougea, Andreas Prentakis, Maria Bozi

Parkinsonism Relat Disord· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral alpha-synuclein levels in patients with genetic and non-genetic forms of Parkinson's disease.
Evangelia Emmanouilidou, Nikolaos Papagiannakis, Stella Kouloulia, Aikaterini Galaziou, Roubina Antonellou, Maria Bozi

Parkinsonism Relat Disord· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Brain-enriched MicroRNAs for detection and discrimination of idiopathic and genetic Parkinson's disease.
Stylianos Ravanidis, Anastasia Bougea, Nikolaos Papagiannakis, Matina Maniati, Christos Koros, Maria Bozi

Mov Disord· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic Characteristics in GBA-Associated Parkinson's Disease: A Study in a Greek Population.
Athina Simitsi, Christos Koros, Marina Moraitou, Nikos Papagiannakis, Roubina Antonellou, Maria Bozi

J Parkinsons Dis· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between environmental factors and different Parkinson's disease subtypes in Greece: Data analysis of the Hellenic Biobank of Parkinson's disease.
Efthalia Angelopoulou, Maria Bozi, Athina-Maria Simitsi, Christos Koros, Roubina Antonelou

Parkinsonism Relat Disord· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter study.
Lisa Wang, Michael G Heckman, Jan O Aasly, Grazia Annesi, Maria Bozi

Neurobiol Aging· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-scale assessment of polyglutamine repeat expansions in Parkinson disease.
Lisa Wang, Jan O Aasly, Grazia Annesi, Soraya Bardien, Maria Bozi

Neurology· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Parkinson's disease risk loci in Greece.
Eleanna Kara, Georgia Xiromerisiou, Cleanthe Spanaki, Maria Bozi, Georgios Koutsis

Neurobiol Aging· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.
Michael G Heckman, Alexis Elbaz, Alexandra I Soto-Ortolaza, Daniel J Serie, Jan O Aasly, Maria Bozi

Neurobiol Aging· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.
Michael G Heckman, Alexandra I Soto-Ortolaza, Jan O Aasly, Nadine Abahuni, Grazia Annesi, Maria Bozi

Mov Disord· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Unified Multiple System Atrophy Rating Scale: intrarater reliability.
Florian Krismer, Klaus Seppi, François Tison, Cristina Sampaio, Anja Zangerl, Maria Bozi

Mov Disord· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants.
Manu Sharma, John P A Ioannidis, Jan O Aasly, Grazia Annesi, Alexis Brice, Maria Bozi

J Med Genet· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-scale replication and heterogeneity in Parkinson disease genetic loci.
Manu Sharma, John P A Ioannidis, Jan O Aasly, Grazia Annesi, Alexis Brice, Maria Bozi

Neurology· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease.
Helen Michelakakis, Georgia Xiromerisiou, Efthimios Dardiotis, Maria Bozi, Demetrios Vassilatis

Mov Disord· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis